|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.98 EUR | -2.00% |
|
-2.00% | -7.55% |
| 2023 | Bio-Gate AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
| 2023 | Bio-Gate AG Signs LOI with North American Medical Device Manufacturer for Trauma Implants | CI |
Bio-Gate AG reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 6.11 million compared to EUR 6.43 million a year ago. Net loss was EUR 1.81 million compared to EUR 0.544122 million a year ago.
Basic loss per share from continuing operations was EUR 0.22 compared to EUR 0.07 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -7.55% | 9.67M | |
| -2.31% | 187B | |
| -3.20% | 106B | |
| -5.04% | 66.9B | |
| +0.20% | 49.45B | |
| +17.29% | 48B | |
| +4.06% | 40.84B | |
| +2.36% | 26.25B | |
| +2.07% | 26.48B | |
| +12.96% | 24.62B |
BIO-GATE AG 
